{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:13:14Z","timestamp":1790669594204,"version":"4.1.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T00:00:00Z","timestamp":1551312000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1093\/jac\/dkz081","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T12:21:53Z","timestamp":1549542113000},"page":"1545-1550","source":"Crossref","is-referenced-by-count":26,"title":["Susceptibility of Legionella pneumophila to antimicrobial agents and the presence of the efflux pump LpeAB"],"prefix":"10.1093","volume":"74","author":[{"given":"Olav Bjarte","family":"Nat\u00e5s","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita L\u00f8v\u00e5s","family":"Brekken","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bernhoff","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4247-8304","authenticated-orcid":false,"given":"Marit Andrea Klokkhammer","family":"Hetland","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iren H\u00f8yland","family":"L\u00f6hr","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Christoffer","family":"Lindemann","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Haukeland University Hospital, Bergen, Norway"},{"name":"Department of Clinical Science, University of Bergen, Bergen, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,2,27]]},"reference":[{"key":"2019051708100124700_dkz081-B1","volume-title":"Annual Epidemiological Report for 2015: Legionnaires\u2019 Disease","year":"2017"},{"key":"2019051708100124700_dkz081-B2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-129-4-199808150-00012","article-title":"Antimicrobial chemotherapy for legionnaires disease: time for a change","volume":"129","author":"Edelstein","year":"1998","journal-title":"Ann Intern Med"},{"key":"2019051708100124700_dkz081-B3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2014full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"2019051708100124700_dkz081-B4","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019051708100124700_dkz081-B5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0732-8893(99)00095-4","article-title":"Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin","volume":"36","author":"Nielsen","year":"2000","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019051708100124700_dkz081-B6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.diagmicrobio.2011.09.016","article-title":"Wild-type distribution and epidemiological cut-off values in clinical Legionella pneumophila serogroup 1 isolates","volume":"72","author":"Bruin","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019051708100124700_dkz081-B7","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1093\/jac\/dku196","article-title":"Isolation of ciprofloxacin-resistant Legionella pneumophila in a patient with severe pneumonia","volume":"69","author":"Bruin","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2019051708100124700_dkz081-B8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.ebiom.2015.07.018","article-title":"Hidden selection of bacterial resistance to fluoroquinolones in vivo: the case of Legionella pneumophila and humans","volume":"2","author":"Shadoud","year":"2015","journal-title":"EBioMedicine"},{"key":"2019051708100124700_dkz081-B9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1128\/AAC.01639-13","article-title":"Antimicrobial activity of solithromycin against clinical isolates of Legionella pneumophila serogroup 1","volume":"58","author":"Mallegol","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019051708100124700_dkz081-B10","first-page":"1327","article-title":"Macrolide resistance in Legionella pneumophila: the role of LpeAB efflux pump","volume":"72","author":"Massip","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2019051708100124700_dkz081-B11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijantimicag.2017.08.001","article-title":"Minimum inhibitory concentration (MIC) distribution among wild-type strains of Legionella pneumophila identifies a subpopulation with reduced susceptibility to macrolides owing to efflux pump genes","volume":"50","author":"Vandewalle-Capo","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"2019051708100124700_dkz081-B12","volume-title":"Antimicrobial Susceptibility Testing of Legionella pneumophila","year":"2017"},{"key":"2019051708100124700_dkz081-B13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.envres.2015.08.013","article-title":"Antibiotic susceptibility of Legionella pneumophila strains isolated from hospital water systems in Southern Italy","volume":"142","author":"De Giglio","year":"2015","journal-title":"Environ Res"},{"key":"2019051708100124700_dkz081-B14","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1128\/JCM.35.11.2841-2845.1997","article-title":"Antigenic lipopolysaccharide components of Legionella pneumophila recognized by monoclonal antibodies: possibilities and limitations for division of the species into serogroups","volume":"35","author":"Helbig","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2019051708100124700_dkz081-B15","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s10096-002-0820-3","article-title":"Pan-European study on culture-proven legionnaires\u2019 disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups","volume":"21","author":"Helbig","year":"2002","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019051708100124700_dkz081-B16","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1128\/JCM.43.5.2047-2052.2005","article-title":"Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila","volume":"43","author":"Gaia","year":"2005","journal-title":"J Clin Microbiol"},{"key":"2019051708100124700_dkz081-B17","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/JCM.00261-07","article-title":"Addition of neuA, the gene encoding N-acylneuraminate cytidylyl transferase, increases the discriminatory ability of the consensus sequence-based scheme for typing Legionella pneumophila serogroup 1 strains","volume":"45","author":"Ratzow","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2019051708100124700_dkz081-B18","doi-asserted-by":"crossref","first-page":"e1005595.","DOI":"10.1371\/journal.pcbi.1005595","article-title":"Unicycler: resolving bacterial genome assemblies from short and long sequencing reads","volume":"13","author":"Wick","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"2019051708100124700_dkz081-B19","doi-asserted-by":"crossref","first-page":"421.","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"2019051708100124700_dkz081-B20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0168-9525(00)02024-2","article-title":"EMBOSS: the European Molecular Biology Open Software Suite","volume":"16","author":"Rice","year":"2000","journal-title":"Trends Genet"},{"key":"2019051708100124700_dkz081-B21","doi-asserted-by":"crossref","first-page":"e02188","DOI":"10.1128\/AAC.02188-16","article-title":"Ribosomal mutations conferring macrolide resistance in Legionella pneumophila","volume":"61","author":"Descours","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2019051708100124700_dkz081-B22","doi-asserted-by":"crossref","first-page":"2176.","DOI":"10.1128\/AAC.44.8.2176-2178.2000","article-title":"In vitro activities of gemifloxacin versus five quinolones and two macrolides against 271 Spanish isolates of Legionella pneumophila: influence of charcoal on susceptibility test results","volume":"44","author":"Garcia","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2019051708100124700_dkz081-B23","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1128\/JCM.35.11.3004-3006.1997","article-title":"Comparison of charcoal- and starch-based media for testing susceptibilities of Legionella species to macrolides, azalides, and fluoroquinolones","volume":"35","author":"Pendland","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2019051708100124700_dkz081-B24","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10096-009-0705-9","article-title":"Distribution of Legionella pneumophila serogroups, monoclonal antibody subgroups and DNA sequence types in recent clinical and environmental isolates from England and Wales (2000-2008)","volume":"28","author":"Harrison","year":"2009","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019051708100124700_dkz081-B25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10096-009-0840-3","article-title":"Legionella pneumophila monoclonal antibody subgroups and DNA sequence types isolated in Canada between 1981 and 2009: Laboratory Component of National Surveillance","volume":"29","author":"Reimer","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019051708100124700_dkz081-B26","doi-asserted-by":"crossref","first-page":"20302.","DOI":"10.2807\/ese.17.43.20302-en","article-title":"Sequence-based typing of Legionella pneumophila serogroup 1 clinical isolates from Belgium between 2000 and 2010","volume":"17","author":"Vekens","year":"2012","journal-title":"Euro Surveill"},{"key":"2019051708100124700_dkz081-B27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/JCM.01973-13","article-title":"Prevalence of sequence types among clinical and environmental isolates of Legionella pneumophila serogroup 1 in the United States from 1982 to 2012","volume":"52","author":"Kozak-Muiznieks","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2019051708100124700_dkz081-B28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10096-007-0392-3","article-title":"Occurrence and distribution of sequence types among Legionella pneumophila strains isolated from patients in Germany: common features and differences to other regions of the world","volume":"27","author":"Borchardt","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2019051708100124700_dkz081-B29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1099\/jmm.0.017509-0","article-title":"Characterization of Legionella pneumophila isolates from patients in Japan according to serogroups, monoclonal antibody subgroups and sequence types","volume":"59","author":"Amemura-Maekawa","year":"2010","journal-title":"J Med Microbiol"},{"key":"2019051708100124700_dkz081-B30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2006.01394.x","article-title":"Legionella: macrolides or quinolones?","volume":"12","author":"Pedro-Botet","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2019051708100124700_dkz081-B31","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ijantimicag.2004.08.019","article-title":"Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing","volume":"25","author":"Stout","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"2019051708100124700_dkz081-B32","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1378\/chest.128.3.1401","article-title":"Fluoroquinolones vs macrolides in the treatment of legionnaires disease","volume":"128","author":"Sabria","year":"2005","journal-title":"Chest"},{"key":"2019051708100124700_dkz081-B33","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1093\/jac\/dku159","article-title":"Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis","volume":"69","author":"Burdet","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"2019051708100124700_dkz081-B34","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1086\/428059","article-title":"Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy","volume":"40","author":"Mykietiuk","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2019051708100124700_dkz081-B35","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1086\/379329","article-title":"Azithromycin in the treatment of Legionella pneumonia requiring hospitalization","volume":"37","author":"Plouffe","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2019051708100124700_dkz081-B36","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.cmi.2017.02.030","article-title":"Levofloxacin versus azithromycin for treating legionella pneumonia: a propensity score analysis","volume":"23","author":"Garcia-Vidal","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2019051708100124700_dkz081-B37","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1093\/cid\/civ157","article-title":"The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia","volume":"60","author":"Gershengorn","year":"2015","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/6\/1545\/28666693\/dkz081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T14:41:20Z","timestamp":1662907280000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/6\/1545\/5366213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,27]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,2,27]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz081","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,2,27]]}}}